A recent study has developed a highly accurate risk prediction framework for preterm birth (PTB) that could broaden the ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving the way for better treatments for autoimmune diseases and cancer immunotherapy ...

A new study presents GeneLLM, an AI-driven framework integrating cfDNA and cfRNA to improve preterm birth detection. Tested ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life ...

Researchers used biochemical and RNA sequencing analyses to explore how disease-associated mutations affect ADAR1’s function, demonstrating that specific mutations impair the editing of shorter ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. It could be an effective alternative to regular ...

The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.